Related Experiment Video
Updated: May 25, 2026
15:27
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
Comprehensive mechanism-based antibody pharmacokinetic modeling.
Jeffrey R Chabot1, Danielle E Dettling, Paul J Jasper
1Pfizer, Inc, Research Technology Center, Cambridge, MA 02139, USA. jeffrey.chabot2@pfizer.com
Summary
This study presents an advanced pharmacokinetic model for antibody therapeutics, improving predictions of drug distribution and tissue penetration. The enhanced model offers superior insights for optimizing therapeutic design in both healthy and diseased states.
Area of Science:
- Pharmacology
- Biotechnology
- Computational Biology
Background:
- Pharmacokinetic models are crucial for predicting therapeutic antibody behavior.
- Current models often lack mechanistic detail for optimizing tissue penetration.
- Understanding antigen distribution in disease states is key for targeted therapies.
Purpose of the Study:
- To develop a more comprehensive pharmacokinetic model for therapeutic antibodies.
- To incorporate organ-specific mechanisms influencing antibody distribution and dynamics.
- To provide a platform for improved therapeutic design and efficacy.
Main Methods:
- Incorporation of endothelial barrier diffusion and transcytosis properties.
- Inclusion of FcRn-mediated recycling in an organ-specific manner.
- Development of a physiologically-based pharmacokinetic (PBPK) model with enhanced mechanistic detail.
Main Results:
- The model accounts for complex factors affecting antibody distribution.
- It allows for organ-specific modeling of therapeutic dynamics.
- It provides a superior alternative to simplified scaling strategies.
Conclusions:
- The enhanced model enables better prediction of therapeutic antibody behavior.
- It facilitates optimized therapeutic design for improved pharmacological effects.
- This platform supports mechanistic translation between animal models and human disease.
Related Concept Videos
01:21Mechanistic Models: Overview of Compartment Models
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...